Thomas Mindermann
Impact in
-
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
- Co-authors
- Charles B. WilsonO. GratzlWerner ZimmerliBernhard SchallerEberhard KirschMarkus TolnayJames TyrrellZ. Rajacic
- Journals
- Acta Neurochirurgica (11 papers)Neurosurgery (6 papers)Journal of neurosurgery (3 papers)Journal of Antimicrobial Chemotherapy (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Thomas Mindermann
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 73
- Endocrinology, Diabetes and Metabolism 512
- Genetics 233
- Neurology 316
- Epidemiology 434
- Surgery 489
Countries citing papers authored by Thomas Mindermann
This map shows the geographic impact of Thomas Mindermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mindermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mindermann more than expected).
Fields of papers citing papers by Thomas Mindermann
This network shows the impact of papers produced by Thomas Mindermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mindermann. The network helps show where Thomas Mindermann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Mindermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 4 | |
| 2 | 2020 | 7 | |
| 3 | 2016 | 2 | |
| 4 | 2016 | 3 | |
| 5 | 2014 | 3 | |
| 6 | 2013 | 23 | |
| 7 | 2012 | 27 | |
| 8 | 2011 | 157 | |
| 9 | 2006 | 9 | |
| 10 | 2005 | 12 | |
| 11 | 2004 | 11 | |
| 12 | 2001 | 33 | |
| 13 | 1999 | 12 | |
| 14 | 1998 | 23 | |
| 15 | 1997 | 10 | |
| 16 | 1997 | 8 | |
| 17 | 1993 | 18 | |
| 18 | 1993 | 65 | |
| 19 | 1993 | 13 | |
| 20 | 1992 | 15 |
About Thomas Mindermann
Thomas Mindermann is a scholar working on Neurology, Genetics, Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Meningioma and schwannoma management (15 papers), Pituitary Gland Disorders and Treatments (10 papers), Head and Neck Surgical Oncology (7 papers), Glioma Diagnosis and Treatment (7 papers), Neurofibromatosis and Schwannoma Cases (5 papers), Adrenal and Paraganglionic Tumors (4 papers), Cerebrospinal fluid and hydrocephalus (4 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (512 citations), Genetics (233 citations), Neurology (316 citations), Epidemiology (434 citations) and Surgery (489 citations). Thomas Mindermann has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Charles B. Wilson, O. Gratzl, Werner Zimmerli, Bernhard Schaller, Eberhard Kirsch, Markus Tolnay, James Tyrrell, Z. Rajacic, Kálmán Kovács and W. Zimmerli. Their work appears in journals such as Acta Neurochirurgica, Neurosurgery, Journal of neurosurgery, Journal of Antimicrobial Chemotherapy and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.